Summarized by Masters of Longevity from Longevity Technology.
Organizers prioritized how to measure functional aging outcomes over selecting a single victor.
Key Takeaways
- XPRIZE funds shared labs for muscle, cognition, and immunity.
- One-year trials can show marker change but not long-term prevention.
- Shared data and infrastructure were found as the prize's main value.
